$ASAN

Snowflake To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday - Lululemon Athletica (NASDAQ

Analysts updated price targets for several companies. Piper Sandler raised Asana's (ASAN) target to $9, Ascendiant cut LiqTech's (LIQT) to $1.3, Needham reduced Planet Labs' (PL) to $40, and raised Zscaler's (ZS) to $215. Rosenblatt cut Ciena's (CIEN) target to $525, BTIG lowered Guidewire's (GWRE) to $220, Bernstein reduced Lululemon's (LULU) to $115. Argus raised Snowflake's (SNOW) target to $450, Barclays increased Dollar Tree's (DLTR) to $160, and Jefferies cut Campbell's (CPB) to $20.

Original reporting
Published Sep 4, 2026, 1:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 3:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Snowflake To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday - Lululemon Athletica (NASDAQ — source image
Decision brief

The 30-second read

$ASANBullishLow
01

Why it matters

Mixed target adjustments suggest varied outlooks across sectors.

02

Market read

Post‑earnings analyst reactions provide modest trading ideas but limited immediate impact.

03

What to watch

Broader macro environment and upcoming earnings could dominate price moves.

Relevance 5/10Novelty 4/10Timing: today

Background

Analyst price target revisions for multiple U.S.-listed companies were reported.

Company-level read

Ticker impact

$ASANBullishMedium confidence
Context

Piper Sandler raised Asana price target from $7 to $9.

Expected impact

Potential modest price gain.

Evidence & confidence

Target increase signals improved outlook.

$LIQTBearishMedium confidence
Context

Ascendiant Capital cut LiqTech price target from $4.4 to $1.3.

Expected impact

Possible near-term decline.

Evidence & confidence

Target cut reflects weaker expectations.

$PLBearishMedium confidence
Context

Needham slashed Planet Labs price target from $53 to $40.

Expected impact

Potential short-term pullback.

Evidence & confidence

Target reduction signals lower growth expectations.

$ZSBullishMedium confidence
Context

Needham raised Zscaler price target from $180 to $215.

Expected impact

Likely modest upside.

Evidence & confidence

Higher target reflects stronger outlook.

$CIENBearishMedium confidence
Context

Rosenblatt cut Ciena price target from $720 to $525.

Expected impact

Possible near-term decline.

Evidence & confidence

Target cut indicates weaker expectations.

$GWRENeutralLow confidence
Context

BTIG cut Guidewire price target from $230 to $220.

Expected impact

Little price movement expected.

Evidence & confidence

Small change suggests modest outlook shift.

$LULUBearishMedium confidence
Context

Bernstein lowered Lululemon price target from $145 to $115.

Expected impact

Potential short-term downside.

Evidence & confidence

Lower target reflects weaker growth view.

$SNOWBullishMedium confidence
Context

Argus Research raised Snowflake price target from $300 to $450.

Expected impact

Possible modest upside.

Evidence & confidence

Higher target signals improved outlook.

Market effects

Analyst target revisions may affect tech and consumer discretionary sectors.

U.S. market sentiment could shift modestly.

Limited to U.S.-listed companies.

Counterpoint

Target changes may be overreacted; price may stabilize.

Key entities

  • Piper Sandler

    Raised Asana target.

  • Ascendiant Capital

    Cut LiqTech target.

Related articles

$SNOWHighAI 9/10

Snowflake Delivers One of Its Best Quarters. Wall Street Is Loving the AI Boom

Snowflake reported strong quarterly results, with adjusted EPS rising to $0.62 and free cash flow at $83.8 million. The company raised its fiscal 2027 revenue outlook to $6.07 billion and adjusted operating margin target to 14.5%. Analysts raised price targets, citing AI-driven growth and strong product revenue. Snowflake has a 'Strong Buy' consensus rating, but valuation concerns remain.

$SNOWMed

Should You Buy Snowflake Stock After Its Recent Surge? The Answer Might Shock You.

Snowflake (NYSE: SNOW) reported 37% product revenue growth in Q2 2027, raising full-year guidance to $6.07B. The company has 14,554 customers, with 9,100 using CoCo and 5,800 using CoWork. Despite strong growth, it posted a $487M GAAP loss in H1 2027, though adjusted profit was $383M. The stock trades at a P/S ratio of 23.1, higher than peers like Amazon, Microsoft, and Alphabet.

$LULUMed

New Lululemon CEO faces multifront battle to refashion company’s edge

Heidi O’Neill, former Nike executive, becomes Lululemon’s new CEO amid challenges. The company faces declining revenues, stock price drop, product issues, and internal conflicts. Analysts highlight the need for innovation, board alignment, and talent retention. Lululemon’s stock has fallen from a peak of around US$500 to roughly $100. O’Neill aims to revitalize the brand and address stakeholder expectations.

$SNOWHighAI 8/10

Snowflake (SNOW) Could Be 328% Overvalued On Raised AI Guidance

Snowflake (SNOW) reported strong Q2 results with raised full-year product revenue guidance due to AI-driven demand. Shares fell 5.41% after earnings but are up 40.23% over 90 days. Analysts suggest SNOW may be 328% overvalued at $337.18, with a fair value estimate of $78.83, citing aggressive growth assumptions and valuation multiples.